AIM ImmunoTech AIM
NYSE AIM
$0.18 +0.01 (+3.11%)
As of: Sep 30, 2026 · 11:53 AM EDT

AIM ImmunoTech (AIM) Convertible Debt (2018 - 2019)

Updated

AIM ImmunoTech (AIM) posted Convertible Debt of $2.29 million for Q3 2019, down 32.5% from $3.39 million a year earlier but up 0.2% from the prior quarter.

Analysis

AIM ImmunoTech (AIM) Convertible Debt (2018 - 2019) Analysis & Trends

At the end of FY2018, AIM ImmunoTech's Convertible Debt came in at $3.41 million.

  • Quarterly Convertible Debt has run from a low of $2.28 million in Q2 2019 to a high of $3.68 million in Q1 2019 over five years.
  • According to Business Quant data, Convertible Debt for the three prior quarters was $2.28 million (Q2 2019), $3.68 million (Q1 2019) and $3.41 million (Q4 2018).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 AIM ImmunoTech 3.08 Mn -18.22 Mn 21,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2019 2.29 Mn
Jun 30, 2019 2.28 Mn
Mar 31, 2019 3.68 Mn
Dec 31, 2018 3.41 Mn
Sep 30, 2018 3.39 Mn
API Access

AIM ImmunoTech Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=AIM&period=max&api_key=YOUR_API_KEY